CD8A and neoplasm: Although sitagliptin was still able to reduce tumor volume when anti-CD4/anti-CD8 was used to deplete T cells, the coexistence of T cells with eosinophils yielded the most optimal result, indicating a synergistic effect between T cells and eosinophils.